v3.25.2
Note 9 - Impairment Expense
12 Months Ended
Jun. 30, 2025
Property, Plant and Equipment [Abstract]  
Note 9 - Impairment Expense

Note 9 - Impairment Expense

 

During the fiscal year ended June 30, 2025, the Company purchased Cardano (ADA) tokens as a long-term reserve and investment. At the time of purchase, management believed ADA represented a viable long-term blockchain asset with potential for growth and ecosystem development. However, subsequent to June 30, 2025, management made the decision to fully divested its ADA token holdings. The Company realized an approximate loss of $12,668 with the sale of these assets. This amount was recognized as an impairment expense in the financial reports for the 2025 fiscal year end filing.